PATENT CLAIM ANALYSIS

Application Number: 16006692
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "226500"]

Abstract:
Disclosed herein are compositions comprising an NSAID such as meloxicam in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability, solubility, or pharmacokinetics of the NSAID for the treatment of conditions such as pain.

Claim (Index 15):
The method of  claim 14 , wherein the solid dosage form is administered for at least 6 days.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 94.0
- Lexical Diversity: 1.39474
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16006642', '16006548', '15902770', '15988104', '15989734']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8228082169753547
- 35 USC 102 Novelty (BERT): 0.5432894604696306
- Combined Prediction Score: 0.7948563413247822
- Mean Citation Score: 370.922006
- Max Citation Score: 384.48800000000006
- Similarity Product: 371.2244921016692

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test